What FTC's 'Killer Acquisition' Theory Means For Pharma Cos.
The Federal Trade Commission recently filed a lawsuit seeking to block Sanofi's acquisition of a proposed exclusive license to a pharmaceutical treatment still under development by Maze Therapeutics Inc., which led...To view the full article, register now.
Already a subscriber? Click here to view full article